IMMX
IMMX
NASDAQ · Biotechnology

Immix Biopharma Inc

Small-Cap Stocks Stocks Under $10 Biotech Stocks Healthcare Stocks
$7.32
+0.12 (+1.67%)
As of Nov 7, 2:09 AM ET ·
Analyst Consensus
Strong Buy
13
Analysts
Moderate
Coverage
Buy 12 92%
Hold 1 8%
Sell 0 0%
Price Target
Analyst Price Target +63.7% upside
Low Target $7.05
Average Target $11.98
High Target $14.20
Current Price $7.32
Current
$7.32
Target
$11.98
$7.05 $11.98 avg $14.20
Scenario Analysis
Bear Case
$7.05
-3.7%
Low target
Base Case
$11.98
+63.7%
Avg target
Bull Case
$14.20
+94.0%
High target
Risk/Reward
25.5x
Highly favorable
Price in Context
52-Week High
$15.10
-51.5% from high
52-Week Low
$2.85
+156.8% from low
50-Day SMA
$10.38
-29.5% vs SMA
200-Day SMA
$9.55
-23.4% vs SMA
RSI (14)
48.3
Neutral
Target vs 52W High
$11.98
-20.7% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 39 82% $257.58 -11.6%
AMGN
Amgen Inc
 Hold 42 43% $190.87 -58.5%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +117.3%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 82% $438.34 -19.9%
MRNA
Moderna Inc
 Hold 31 35% $149.45 -41.2%
REGN
Regeneron Pharmaceuticals
 Buy 37 70% $76.80 -91.5%
NTRA
Natera Inc
 Strong Buy 30 90% $142.91 -54.0%
RVMD
Revolution Medicines Inc
 Strong Buy 29 93% $114.11 -40.7%